Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hindricks

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Arzneimittel-Forschung|September 1, 1989
Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochlorideI Chiladakis, G Hindricks, W Haverkamp, et al.
The American Journal of Cardiology|November 14, 1997
Antiarrhythmic therapy--future trends and forecast for the 21st centuryD Böcker, M Block, G Hindricks, et al.
European Heart Journal|January 1, 1993
Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosisG Hindricks, D Böcker, W Konertz, et al.
European Heart Journal|August 1, 1987
Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarctionJ Thale, H Gülker, G Hindricks, et al.
Grudnaia I Serdechno-Sosudistaia Khirurgiia|August 1, 1991
[Non-pharmacological treatment of arrhythmia using the method of trans-catheter ablation]W Haverkamp, G Hindricks, M Borggrefe, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2000
[Idiopathic right ventricular tachycardia or arrhythmogenic right ventricular tachycardia?]A Kuhn, H Kottkamp, H Thiele, et al.
Herzschrittmachertherapie & Elektrophysiologie|November 27, 2012
[Non-fluoroscopic catheter tracking: the MediGuide™ system]Philipp Sommer, S Rolf, S Richter, et al.
European Heart Journal|August 1, 1987
Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusionW Haverkamp, J Thale, H Gülker, et al.
Journal of Internal Medicine|March 19, 2016
Current controversies in determining the main mechanisms of atrial fibrillationU Schotten, D Dobrev, P G Platonov, et al.
European Heart Journal|July 1, 1995
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillationG Hindricks, H Kottkamp, X Chen, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Arzneimittel-Forschung|September 1, 1989
Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochlorideI Chiladakis, G Hindricks, W Haverkamp, et al.
The American Journal of Cardiology|November 14, 1997
Antiarrhythmic therapy--future trends and forecast for the 21st centuryD Böcker, M Block, G Hindricks, et al.
European Heart Journal|January 1, 1993
Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosisG Hindricks, D Böcker, W Konertz, et al.
European Heart Journal|August 1, 1987
Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarctionJ Thale, H Gülker, G Hindricks, et al.
Grudnaia I Serdechno-Sosudistaia Khirurgiia|August 1, 1991
[Non-pharmacological treatment of arrhythmia using the method of trans-catheter ablation]W Haverkamp, G Hindricks, M Borggrefe, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2000
[Idiopathic right ventricular tachycardia or arrhythmogenic right ventricular tachycardia?]A Kuhn, H Kottkamp, H Thiele, et al.
Herzschrittmachertherapie & Elektrophysiologie|November 27, 2012
[Non-fluoroscopic catheter tracking: the MediGuide™ system]Philipp Sommer, S Rolf, S Richter, et al.
European Heart Journal|August 1, 1987
Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusionW Haverkamp, J Thale, H Gülker, et al.
Journal of Internal Medicine|March 19, 2016
Current controversies in determining the main mechanisms of atrial fibrillationU Schotten, D Dobrev, P G Platonov, et al.
European Heart Journal|July 1, 1995
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillationG Hindricks, H Kottkamp, X Chen, et al.
Pageof 15